From a Different Way | GenomeWeb

From a Different Way

While personalized medicine promises more individualized treatments, Janet Woodcock, director of the US Food and Drug Administration's Center for Drug Evaluation and Research, says that clinical trials have to change to be able to study such drugs that are effective only in small numbers of patients, reports the PharmExecBlog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Trends to Watch

Mish Mash of Cells

FDA Approved

Biopsy Troubles

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.